ESR1 and breast cancer: Current studies in solid tumors found several molecules with relatively more direct interaction to icaritin above the common signal pathways, such as estrogen receptor in breast cancer cells [11, 23] and sphingosine kinase 1 in hepatocellular carcinoma cells [14].